Coloplast A/S (OCSE:COLO B) EV-to-EBIT : 30.54 (As of May. 12, 2024)

Coloplast A/S EV-to-EBIT Chart

Coloplast A/S Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
EV-to-EBIT		Get a 7-Day Free Trial					34.92	39.04	34.56	29.02	28.01

Coloplast A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															33.03	31.78	28.01	28.21	33.34

Competitive Comparison of Coloplast A/S's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Coloplast A/S's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast A/S's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's EV-to-EBIT falls into.

Coloplast A/S EV-to-EBIT Calculation

Coloplast A/S's EV-to-EBIT for today is calculated as:

Coloplast A/S's current Enterprise Value is kr213,824 Mil.
Coloplast A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7,001 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S  (OCSE:COLO B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Coloplast A/S's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Coloplast A/S's Enterprise Value for the quarter that ended in Mar. 2024 was kr233,447 Mil.
Coloplast A/S's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7,001 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast A/S EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast A/S (OCSE:COLO B) Business Description